149 related articles for article (PubMed ID: 1584833)
1. Catalepsy induced by striatal acetylcholinesterase inhibition with fasciculin in rats.
Castelló ME; Bolioli B; Dajas F
Pharmacol Biochem Behav; 1992 Mar; 41(3):547-50. PubMed ID: 1584833
[TBL] [Abstract][Full Text] [Related]
2. Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo.
Kaneko M; Sato K; Horikoshi R; Yaginuma M; Yaginuma N; Shiragata M; Kumashiro H
Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):53-7. PubMed ID: 1378633
[TBL] [Abstract][Full Text] [Related]
3. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
Massotti M
Pharmacol Res Commun; 1977 Apr; 9(4):381-9. PubMed ID: 559310
[No Abstract] [Full Text] [Related]
4. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
de Graaf CJ; Korf J
Psychopharmacology (Berl); 1986; 90(1):54-7. PubMed ID: 3094062
[TBL] [Abstract][Full Text] [Related]
5. Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms.
Sanberg PR; Emerich DF; el-Etri MM; Shipley MT; Zanol MD; Cahill DW; Norman AB
Pharmacol Biochem Behav; 1993 Oct; 46(2):303-7. PubMed ID: 8265684
[TBL] [Abstract][Full Text] [Related]
6. Differential cholinergic and non-cholinergic actions of acetylcholinesterase in the substantia nigra revealed by fasciculin-induced inhibition.
Dajas F; Silveira R; Costa G; Castello ME; Jerusalinsky D; Medina J; Levesque D; Greenfield S
Brain Res; 1993 Jul; 616(1-2):1-5. PubMed ID: 7689409
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical and behavioral correlates of unilateral striatal acetylcholinesterase inhibition by fasciculin in rats.
Bolioli B; Castelló ME; Jerusalinsky D; Rubinstein M; Medina J; Dajas F
Brain Res; 1989 Dec; 504(1):1-6. PubMed ID: 2598003
[TBL] [Abstract][Full Text] [Related]
8. Effects of local inhibition of locus coeruleus acetylcholinesterase by fasciculin in rats.
Abó V; Viera L; Silveira R; Dajas F
Neurosci Lett; 1989 Apr; 98(3):253-7. PubMed ID: 2471117
[TBL] [Abstract][Full Text] [Related]
9. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat.
Jaskiw GE; Bongiovanni R
Psychopharmacology (Berl); 2004 Feb; 172(1):100-7. PubMed ID: 14586541
[TBL] [Abstract][Full Text] [Related]
10. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
Andersen HL; Kilpatrick IC
Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
Ahtee L
Br J Pharmacol; 1975 Nov; 55(3):381-5. PubMed ID: 1239323
[TBL] [Abstract][Full Text] [Related]
12. Rat striatal acetylcholinesterase inhibition by fasciculin (a polypeptide from green mamba snake venom).
Dajas F; Bolioli B; Castello ME; Silveira R
Neurosci Lett; 1987 Jun; 77(1):87-91. PubMed ID: 3601220
[TBL] [Abstract][Full Text] [Related]
13. Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats.
Tucci S; Fernandez R; Baptista T; Murzi E; Hernandez L
Brain Res Bull; 1994; 35(2):125-33. PubMed ID: 7953768
[TBL] [Abstract][Full Text] [Related]
14. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic mediation of beta-endorphin-induced catalepsy.
Van Loon GR; Kim C
Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
[TBL] [Abstract][Full Text] [Related]
16. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
Calderon SF; Sanberg PR; Norman AB
Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
[TBL] [Abstract][Full Text] [Related]
17. Dopamine metabolites and catalepsy after lithium and haloperidol.
Bowers MB; Rozitis A
Eur J Pharmacol; 1982 Feb; 78(1):113-5. PubMed ID: 7200429
[TBL] [Abstract][Full Text] [Related]
18. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
Zetterström T; Sharp T; Ungerstedt U
Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of ceruletide on haloperidol-induced catalepsy in rats.
Ibii N; Ikeda M; Takahara Y; Eigyo M; Akiyoshi T; Matsushita A
Peptides; 1989; 10(4):779-83. PubMed ID: 2587420
[TBL] [Abstract][Full Text] [Related]
20. Serotonin--dopamine interactions in the nigrostriatal system.
Waldmeier PC; Delini-Stula AA
Eur J Pharmacol; 1979 May; 55(4):363-73. PubMed ID: 572774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
